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Background. Oxidative-nitrative stress and poly (ADP-ribose) polymerase activation have been previously observed in healthy and
gestational diabetic pregnancies, and they were also linked to the development of metabolic diseases. The aim of the present study
was to examine these parameters and their correlation to known metabolic risk factors following healthy and gestational diabetic
pregnancies. Methods. Fasting and 2 h postload plasma total peroxide level, protein tyrosine nitration, and poly (ADP-ribose)
polymerase activation were measured in circulating leukocytes three years after delivery in women following healthy, “mild”
(diet-treated) or “severe” (insulin-treated) gestational diabetic pregnancy during a standard 75 g OGTT. Nulliparous women and
men served as control groups. Results. Fasting plasma total peroxide level was signiﬁcantly elevated in women with previous
pregnancy (B = 0.52± 0.13; p < 0 001), with further increase in women with insulin-treated gestational diabetes (B = 0 36 ± 0 17;
p < 0 05) (R2 = 0 419). Its level was independently related to previous pregnancy (B = 0 47 ± 0 14; p < 0 01) and current CRP
levels (B = 0 06 ± 0 02; p < 0 05) (R2 = 0 306). Conclusions. Elevated oxidative stress but not nitrative stress or poly (ADP-ribose)
polymerase activation can be measured three years after pregnancy. The increased oxidative stress may reﬂect the cost of
reproduction and possibly play a role in the increased metabolic risk observed in women with a history of severe gestational
diabetes mellitus.
1. Introduction
Several previous studies examined the role of oxidative-
nitrative (ON) stress and poly (ADP-ribose) polymerase-1
(PARP) activation in healthy pregnancy and in the pathogen-
esis of pregnancy-related complications like gestational dia-
betes (GDM). Blood and urinary markers of increased ON
stress and PARP activation have been observed during preg-
nancy, and a further elevation of these parameters has been
shown in gestational diabetes [1–4]. Less is known about
the possible persistence of ON stress and PARP activation
after delivery.
Increased formation of oxygen- and nitrogen-derived
reactive species and reduced antioxidant capacities are the
hallmarks of oxidative-nitrative (ON) stress. Peroxynitrite
(ONOO−) is a reactive oxidant that is formed in the reaction
of superoxide (O2
−) and nitric oxide (NO) [5]. Peroxynitrite
and hydroxyl radicals are potent inducers of DNA single-
strand breakage, which is the obligatory trigger of the activa-
tion of the constitutive nuclear enzyme poly (ADP-ribose)
polymerase-1 (PARP). PARP uses NAD+ as substrate to pro-
duce poly (ADP-ribose) (PAR) and binds it to several nuclear
proteins (PARylation), such as histones. Overactivation
results in rapid reduction of intracellular NAD+, leading to
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energy depletion, and necrotic cell death. PARP-1 also
interacts with and stimulates the production of the proin-
ﬂammatory nuclear factor-κB (NF-κB) transcription factor.
Cell necrosis and proinﬂammatory processes further ele-
vate ON stress, forming a vicious circle. There are various
endogenous factors inhibiting the activation of PARP, for
example, estrogen and the active form of vitamin D3
(1,25-dihydroxyvitamin D3) [6, 7].
The role of ON stress and consequent PARP activation in
the pathogenesis of T2D and various cardiovascular disorders
(atherosclerosis, hypertension, myocardial infarction, and
stroke) has been well established. ON stress plays a role in
the development of insulin resistance and pancreatic beta cell
death and dysfunction [8–10]. The potential pathogenic role
of increasedONstress andPARP activation has also been pro-
posed during the development of various pregnancy-related
complications, such as preeclampsia, GDM, or intrauterine
retardation [1, 3, 4]. Increased oxidative stress can be observed
even during the course of a healthy pregnancy [4].
On the other hand, the potential late consequences of
pregnancy-associated ON stress and PARP activation (such
as T2D and cardiovascular disease) have not yet been inves-
tigated. The aim of the present study was to examine the
potential persistence of ON stress and PARP activation three
years after a healthy or diabetic pregnancy in the fasting state
and following a 75 g oral glucose tolerance test. In order to
estimate the eﬀect of gender and pregnancy, additional con-
trol groups of nulliparous women and men were also
included. We further evaluated whether the severity of
GDM (the requirement of insulin treatment) had an eﬀect
on ON stress and PARP activation. In order to assess poten-
tial covariates of ON stress and PARP activation that may
link them to late metabolic complications, contemporaneous
metabolic risk factors were also evaluated.
2. Materials and Methods
2.1. Participants. The participants of the present nested
case-control study were recruited as a subcohort of a
follow-up screening program for GDM pregnancies at the
1st Department of Medicine, Semmelweis University Faculty
ofMedicine (Budapest, Hungary). Forty-six women with pre-
vious GDM (diet-treated GDM (DGDM), n = 36; insulin-
treated GDM (IGDM), n = 10) and 25 with normal glucose
tolerance during pregnancy (PREG) agreed to participate in
the sample collection for oxidative stress measurements.
To further elucidate the association between gender,
previous pregnancy, and ON stress, age- and BMI-
matched healthy nulliparous women (NULL, n = 16) and
men (MALE, n = 15) were also investigated. All procedures
of the follow-up investigation were approved by the
Regional Ethics Committee of Semmelweis University
(124/2007), and written informed consent was acquired
from all participants.
2.2. Clinical Examination. The follow-up clinic consists of a
clinical assessment and a 75 g oral glucose tolerance test
(OGTT) with repeated blood sampling run at the 1st
Department of Medicine, Semmelweis University Faculty of
Medicine (Budapest, Hungary).
All participants started with an interviewer-assisted
questionnaire that included sociodemographic data (age,
gender, education, family income, lifestyle), general medi-
cal (medication, known illnesses, family history), and
obstetrical (previous pregnancies) inquiries. For further
analysis, current smoking was deﬁned as ≥1 cigarette/day
on a weekly average; educational attainment was divided
into 4 categories (primary school/vocational secondary
school/nonvocational secondary school/college or univer-
sity degree), and family income into 5 categories (monthly
income per capita <185€/185–369€/370–555€/556–740
€/>740€). Following the questionnaire, height and weight
were measured on a calibrated stadiometer in light cloth-
ing. BMI was calculated as weight (kg)/(height (m))2.
Following fasting blood draws for glucose, insulin, HbA1c,
C-reactive protein, 25-OH vitamin D3, estradiol, and ON
stress determination, a standard 75 g OGTT was performed
according to the WHO recommendation [11]. During the
test, blood samples for glucose and insulin determinations
were also collected at 30, 90, and 120minutes after the glu-
cose load; and for ON stress investigation at 120minutes
after glucose load.
All routine laboratory determinations were done in the
Central Laboratory of Semmelweis University. Glucose levels
were determined by a glucose oxidase method; serum insulin
and estradiol by electrochemiluminescence immunoassay
(Roche, Basel, Switzerland; Hitachi Cobas 601); HbA1c by
HPLC (Bio-Rad, Brussels, Belgium); C-reactive protein
(CRP) by immunoturbidimetry (Beckman Coulter, Brea,
CA, USA); and vitamin D3 by chemiluminescent immunoas-
say (Liaison XL, DiaSorin, Salugga, Italy).
Early insulin response (EIR:Δinsulin30 min/Δglucose30min)
and area under the glucose curve (AUC glucose using the
trapezoid technique) were calculated. Homeostasis model
assessment insulin secretion (HOMA2B) and insulin sensi-
tivity (HOMA2S) were determined using the HOMA
calculator v2 (Diabetes Trial Units, University of Oxford,
Oxford, UK).
2.3. ON Stress and PARP Activation. ON stress-related
parameters were determined in the fasting state and 2 hours
after an OGTT. Plasma total peroxide level was measured by
the Oxystat kit (Biomedica, Vienna, Austria) according to the
user’s manual. Erroneous results due to hemolysis were
excluded. To measure protein tyrosine nitration and PARP
activation, circulating mononuclear leukocytes were isolated
by gradient centrifugation (Histopaque-1077, Sigma/Aldrich,
St. Louis, MO, USA). Protein tyrosine nitration and PARP
activation were estimated by immunohistochemical labeling
of methanol-ﬁxed leukocyte smears with antinitrotyrosine
(NT) (Calbiochem, Temecula, CA, USA; 1 : 80, overnight,
4°C) and anti-PAR (Calbiochem; 1 : 1000, overnight, 4°C)
antibodies. Mouse and rabbit immunoglobulin-speciﬁc bio-
tinylated antibody (Vector Laboratories, Burlingame, CA,
USA) served as secondary labeling. Avidin–horseradish per-
oxidase complex and black-colored nickel enhanced
diamino-benzidine (Vector) was used to visualize labeling;
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counterstaining was red-colored Nuclear Fast Red (Sigma)
(Figure 1). The ratio of the positive cellular area and total
cellular area was calculated by computer-based evaluation
(MBFImageJ). Low cell count smears were excluded from
the analysis.
2.4. Statistical Analysis. Descriptive statistics are given as
mean± SD for normally distributed variables and median
(interquartile range) for nonnormally distributed variables.
Participant characteristics by study group were compared
using one-way and two-way ANOVA or Kruskal-Wallis tests
with the appropriate post hoc investigations. Variables that
violated the normality assumption (insulin, HOMA2B,
HOMA2S, EIR, CRP, estradiol, plasma total peroxide, leuko-
cyte NT, leukocyte PAR) were log-transformed before using
them in regression models.
To investigate the association of ON stress markers and
their change during OGTT with grouping variables (female
sex, prior pregnancy, prior GDM, prior insulin treatment),
multiple linear regression models and ﬁxed-eﬀect hierarchi-
cal linear speciﬁcations were used.
To explore the potential association between found pre-
dictors and ON stress parameters, the above models were
further adjusted for clinical anthropological and laboratory
parameters and socioeconomic data (variables presented in
Table 1) if they were associated to the given ON stress param-
eter according to the Pearson correlation. As several gender-
related parameters may alter ON stress such as estradiol and
several of the variables of interest are meaningless in males
such as GDM and parity, these analyses were limited to
female participants.
Statistical analyses were performed by the SPSS (IBM,
Armonk, NY, U.S.A.) and Graphpad Prism (Graphpad
Software Inc., La Jolla, CA, USA) software. In all cases,
p < 0 05 was considered signiﬁcant.
3. Results
3.1. Characteristics of Participants at Follow-Up. The results
of the anthropometric, clinical laboratory measurements,
and socioeconomic data for each study group are presented
in Table 1. Age, BMI, fasting glucose and insulin, and HbA1c
were similar in all groups, such as parity for those groups that
had a prior pregnancy. Regardless of its severity, a previous
diabetic pregnancy resulted in increased 120min postload
glucose levels compared to all other groups. Consequently,
AUC glucose (a measure of glycemic excursion during
OGTT) was signiﬁcantly elevated in the previous DGDM
compared to the PREG group. Diﬀerences in insulin levels
were less prominent; they reached statistical signiﬁcance only
between the largest groups (DGDM versus PREG) in the 90-
minute and 120-minute postload insulin. The prevalence of
carbohydrate metabolism disorder (prediabetes and diabe-
tes) was higher in both GDM group compared to women
with prior healthy pregnancy.
No signiﬁcant diﬀerences were found in measures of
insulin sensitivity or secretion (HOMA-2B, HOMA-2S, and
EIR) or HbA1c between the groups. There were no clinically
relevant diﬀerences in CRP, vitamin D3, or estrogen levels
between any of the groups.
Twenty percent of all participants were current smokers;
smoking was most prevalent among males. The majority of
the participants was well educated and had an average Hun-
garian monthly income. Women having children had lower
income per capita than nulliparous women, probably due
to the higher number of dependents in the family and mater-
nity leave. Women in the IGDM group were signiﬁcantly less
educated and had lower income than members of the other
groups [12].
3.2. Predictors of ON Stress and PARP Activation in the
Fasting State. According to the analysis of plasma total per-
oxide level data with two-way ANOVA, it revealed that all
previously pregnant group (PREG, DGDM, IGDM) had sig-
niﬁcantly higher fasting plasma total peroxide level com-
pared to nulliparous women (NULL) and men (MALE)
(Figure 2).
Fasting plasma total peroxide levels were further ana-
lyzed by regression models in order to identify the isolated
eﬀects of grouping variables (female sex, prior pregnancy,
prior GDM, prior insulin treatment). The regression analysis
suggested higher plasma total peroxide level among women
(a)
100 휇m
(b)
Figure 1: Immunostaining of leukocyte smears. (a) Representative microscopic image of leukocyte smears stained against nitrotyrosine.
Black-colored precipitate indicates the diﬀuse labeling. Magenta-colored NFR served as counterstain. Black-colored arrows show positively
stained cells. (b) Photograph of smear immunolabeled with anti-PAR antibody. Black color represents positive nuclear staining.
Counterstaining was NFR. Red arrows point on positive leukocytes.
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(Table 2, Model 1); however, further adjustment for previous
pregnancy reduced this diﬀerence to nonsigniﬁcance
(Table 2, Model 2), suggesting that the observed gender
diﬀerence only reﬂects the elevated levels among women
with previous pregnancy. Prior gestational diabetes had
no association with plasma total peroxide (Table 2, Model
3, 4); however, more severe cases (insulin treatment during
pregnancy) presented with a signiﬁcantly increased level
(Table 2, Model 4, 5).
Neither tyrosine nitration nor protein PARylation was
inﬂuenced by any of the above predictors (Figure 2).
3.3. The Eﬀect of Contemporaneous Metabolic Risk Factors on
the Association between Predictors and ON Parameters
among Women. Ninety and 120minute postload glucose
levels, CRP, and monthly income were signiﬁcant univariate
correlates of plasma peroxide levels. However, according to
a multivariate linear regression model—including these
variables together with already identiﬁed predictors such
as prior pregnancy and prior insulin treatment—both
insulin treatment and monthly income became nonsigniﬁ-
cant, and only previous pregnancy and plasma CRP levels
were found to be independent determinants (R2 = 0 306,
Pregnancy: B = 0 47 ± 0 14, p = 0 002, CRP: B = 0 06 ±
0 02, p = 0 015).
In a further model, we found a potential interaction
between CRP and previous childbearing suggesting that
increasing CRP levels is only related to higher plasma
peroxide level in previously pregnant women but not
in nulliparous women (R2 = 0 368, Pregnancy: B = 0 6 ±
0 15, p < 0 001, CRP: NS, Pregnancy ∗CRP: B = 0 1 ±
0 04, p = 0 023).
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Figure 2: Pre- and postload values of ON stress and PARP activation markers in the study groups. (a) Plasma total peroxide. In the fasting
state, all previously pregnant groups had signiﬁcantly increased plasma total peroxide level compared to men and nulliparas. The two-hour
postload value of this parameter was similar to that seen in the fasting state. The between-group diﬀerences in postload levels were also similar
to those found in the fasting state; however, only the DGDM and IGDM groups were signiﬁcantly diﬀerent from nulliparas. (b) Protein
tyrosine nitration in circulating mononuclear cells. There was no signiﬁcant between-group diﬀerence of protein nitration neither in the
fasting nor in the postload state. On the other hand, the postload values were signiﬁcantly higher compared to the fasting state. (c) Protein
PARylation in circulating mononuclear cells. Similar changes can be observed in the case of protein PARylation that was observed
regarding protein nitration. In the boxplot, the central line shows the median; the box represents the interquartile range; and the
whiskers mark the minimum and maximum values. Two-way repeated measures ANOVA, Tukey post hoc test. ###: p < 0 001 versus
MALE; ł: p < 0 05 versus NULL; łł: p < 0 01 versus NULL; łłł: p < 0 001 versus NULL; a: p < 0 05 preload versus postload.
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In women with previous pregnancy, vitamin D3 levels
and EIR correlated with fasting leukocyte nitrotyrosine levels.
According to the multiple regression model, the sole inde-
pendent predictor of leukocyte nitrotyrosine levels was
decreased plasma vitamin D3 (R
2 = 0 205, B = −0 04 ± 0 01,
p = 0 002).
Fasting protein PARylation was associated only with
socioeconomic status (income and education). Surpris-
ingly, having a secondary school degree was related to
decreased PARP activation compared to a university
degree (R2 = 0 152, B = −0 78 ± 0 36, p = 0 036).
3.4. Changes in ON Stress and PARP Activation during the
OGTT. Plasma peroxide levels showed no overall change or
any between-group diﬀerences during the OGTT according
to our mixed model analysis.
Protein nitration increased during the OGTT overall;
however, this increase was signiﬁcantly smaller among
those with insulin-treated GDM during pregnancy
(Figure 2, Table 3).
Leukocyte PARP activity also increased signiﬁcantly dur-
ing the OGTT without any between-group diﬀerences
(Figure 2, Table 3).
3.5. The Eﬀect of Contemporaneous Metabolic Risk Factors on
the Association between OGTT-Related Changes in ON Stress
and Its Predictors. In women, the 2-hour change of plasma
total peroxide level during the OGTT negatively correlated
with HbA1c levels while the change in protein nitration
was positively related to EIR. According to the mixed (ﬁxed
eﬀect) model, the change in plasma total peroxide level fol-
lowing the glucose load was negatively associated with HbA1c
levels (Table 4). No independent determinant was found for
changes in protein nitration or PARP activation.
4. Conclusion
According to our present results, previous pregnancy
increased the fasting level of plasma total peroxide, an oxida-
tive stress marker 3 years after delivery, while a GDM preg-
nancy, per se, was not associated with elevated levels. More
severe cases of GDM (those on insulin treatment during
pregnancy) however showed further increases in the oxida-
tive stress marker. Nitrative stress and PARP activation,
reﬂected by protein nitration and PARylation in circulating
mononuclear cells, were similar in all groups, suggesting that
female gender, prior pregnancy, or prior GDM had no eﬀect
on these variables.
As ON stress measures were obtained only at one time
point in our study, we can only speculate whether our ﬁnd-
ings reﬂect a persistence of the elevated oxidative stress from
the time of pregnancy, or it develops later, due to other post-
labor processes. In a recent study by Ziomkiewicz et al., the
number of pregnancies during a lifetime was shown to have
positive correlation to oxidative stress, which according to
the authors’ hypothesis may reﬂect the cost of reproductive
eﬀort in humans [13]. Similar ﬁndings were published by
Mutlu and colleagues who found that total oxidant status
and oxidative stress index were elevated, while total
Table 2: Potential predictors of plasma total peroxide level based on multiple linear regression with log-transformed plasma total peroxide as
the outcome. To investigate the association between gender, previous pregnancy, previous GDM, GDM severity, and ON stress, a set of
multiple linear regression models were built with the individual addition of dummy coded grouping variables as predictors. For the ﬁnal
model, only statistically signiﬁcant terms were retained. Model 1: adjusted for female sex; Model 2: Model 1 + previous pregnancy; Model
3: Model 2 + previous GDM; Model 4: Model 3 + previous insulin treatment; Model 5: Model 4 with the removal of the nonsigniﬁcant
GDM term. Female sex was associated with increased oxidative stress (Model 1) that was abolished by including previous pregnancy into
the model (Model 2). Previous GDM did not have additional elevating eﬀect on plasma total peroxide level upon previous healthy
pregnancy (Model 3); however, previous insulin treatment itself had a positive additional impact on oxidative stress (Model 5).
Independent variable Model 1 Model 2 Model 3 Model 4 Model 5
Female sex 0.75 ∗∗ (0.15) 0.29 (0.73) 0.29 (0.17) 0.29 (0.17) 0.29 (0.17)
Pregnancy 0.57 ∗∗∗ (0.13) 0.43 ∗∗ (0.15) 0.43 ∗∗ (0.15) 0.52 ∗∗∗ (0.13)
Previous GDM 0.207 (0.12) 0.15 (0.12)
Previous insulin treatment 0.30 (0.18) 0.36 ∗ (0.17)
R2 0.241 0.385 0.408 0.430 0.419
Independent variable: log plasma total peroxide, n = 81, values are estimated eﬀect sizes: B (SE), (∗: p ≤ 0 05; ∗∗: p ≤ 0 01; ∗∗∗: p ≤ 0 001).
Table 3: Eﬀect of OGTT and grouping variables on protein
nitration and PARP activation according to mixed models with
ﬁxed eﬀects. Diﬀerence in ON stress between the fasting and the
postload state was assessed by the inclusion of the interaction
between time (index) and the given predictors. As the same
subjects were observed at two time points, observations are not
independent (they are clustered within individuals), thus ﬁxed-
eﬀects hierarchical linear speciﬁcation was used. Both nitrative
stress and PARP activity increase by the 2nd hour of the OGTT
due to the glucose load (index). In case of tyrosine nitration,
previous insulin treatment during index pregnancy signiﬁcantly
decreases the increment (index ∗ previous insulin treatment).
PARP activation is not altered by the grouping variables.
Independent variable log NT log PAR
Dependent variable
Index 0.33∗∗∗ (0.085) 0.37∗∗ (0.13)
Previous insulin treatment 0.08 (0.43)
Index ∗ previous insulin treatment −0.65∗∗ (0.28)
N = 86 and 84, respectively. Values are estimated eﬀect sizes: B (SE)
(∗ : p ≤ 0 05; ∗∗: p ≤ 0 01; ∗∗∗: p ≤ 0 001).
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antioxidant capacity was reduced in newborns’ cord blood of
multiparous mothers compared to primiparous women
[14]. In multiparous rats, increased oxidative stress and
peroxynitrite formation was found compared to virgins,
which was associated with reduced endothelium-dependent
relaxation of coronary arteries and aortic rings [15]. Our
results extend ﬁndings in animal models, and together with
our knowledge about the role of oxidative stress in the path-
ogenesis of T2D, they suggest that increased oxidative stress
may play a role in the association between increasing number
of healthy pregnancies and the development of metabolic
morbidities in women.
Several previous studies from diﬀerent geographical
regions examined the eﬀect of childbearing and child-
rearing on metabolic [16–19] and cardiovascular [20, 21]
risk. Previous pregnancies and especially multi- and grand-
multiparity were shown to have negative eﬀects on glucose
homeostasis and diabetes risk. However, lifestyle changes
and socioeconomic factors were claimed to be important or
even exclusive reasons for this phenomenon [16, 19]. Our
results suggest that socioeconomic factors have little eﬀect
on ON stress parameters, as socioeconomic status had no
eﬀect on the pregnancy-oxidative stress association.
Given the bidirectional association between reactive
oxygen species and metabolic syndrome, T2D and its com-
plications, and our observation that more severe GDM fur-
ther increases oxidative stress, we suggest the possibility of
a vicious cycle from oxidative stress to the well-described ele-
vated risk for metabolic and cardiovascular diseases of prior
severe GDM. This hypothesis is further reinforced by the
results of the Framingham Oﬀspring Study, where systemic
oxidative stress (urine 8-epi-prostaglandin F2α) was found
to be in association with insulin resistance in individuals at
average or elevated risk of diabetes even after adjustment
for BMI [22]. Our results also correspond to the observation
that insulin treatment during a GDM pregnancy (reﬂecting
its severity) increases diabetes risk in later life [23].
Although the direct pathogenic role of CRP in T2D
development has been questioned recently, it is widely
accepted that it is an important marker of diabetes risk
as supported by a recent meta-analysis [24]. One of the
possible mechanisms leading from subclinical inﬂamma-
tion to the development of T2D is the elevated production
of reactive oxygen and nitrogen species, which, in turn,
further activates proinﬂammatory processes [25]. In our
study, the inﬂammatory marker CRP was independently
associated with oxidative stress, supporting this concept.
The ﬁnding that increased CRP induces oxidative stress
in previously pregnant women and not in their nulliparous
mates may indicate the higher susceptibility of these
women for subclinical inﬂammation.
Our ﬁnding that fasting nitrotyrosine levels correlate
with early insulin response is consistent with previous studies
[26, 27] showing that insulin resistance with decreasing insu-
lin secretion leads to increased production of nitrogen-
derived reactive species.
Although the exact mechanism is not fully explored,
emerging evidence suggest that decreased vitamin D3 levels
predict metabolic and cardiovascular diseases [28–31]. The
association may be driven by the role of decreased vitamin
D3 in oxidative stress, nitric oxide production, nitrative
stress, and even PARP activation [32, 33]. In our participants,
fasting nitrotyrosine accumulation in circulating leukocytes
was negatively associated with plasma vitamin D3 levels and
thus is in agreement with the hypothesis that vitamin D3 sup-
presses nitrative stress.
According to our data, nitrative stress and PARP activa-
tion, but not oxidative stress, were increased two hours after
a glucose load. These changes were not inﬂuenced by gender,
previous pregnancy, or GDM. There is an ongoing debate
about the eﬀect of acute hyperglycemia (oral glucose load)
on oxidative stress and antioxidant capacity [34]. Our ﬁnd-
ings are consistent with previous studies showing that plasma
nitrotyrosine levels are increased 2 hours after an OGTT,
while plasma malonyl dialdehyde levels are not altered by
glucose consumption [35, 36]. Although on the group level
oxidative stress was not elevated due to glucose load
during OGTT, HbA1c levels were negatively associated
with changes in oxidative stress during the OGTT. The
signiﬁcance and possible mechanism of this phenomenon
need further investigation.
Elevated oxidative stress be measured three years after
healthy pregnancy, while in case of previous insulin-treated
GDM, its magnitude is even bigger. Nitrative stress and poly
(ADP-ribose) polymerase activation are not altered by previ-
ous childbearing; however, they are increased by the acute
Table 4: Eﬀect of OGTT, grouping variables, and clinical variables
on plasma total peroxide level according to mixed models with
ﬁxed eﬀects. To explore the potential associations between the
identiﬁed grouping variable predictors to the changes in plasma
total peroxide level in women, the mixed model was also adjusted
for those variables and for their time interactions that were
independent predictors of fasting plasma total peroxide level
(CRP) or univariately related (Pearson correlation) to the change
in plasma total peroxide level during OGTT (HbA1c). Including all
independent determinants of plasma total peroxide level and
parameters that show correlation with the change of the total
peroxide level after glucose load showed that only HbA1c acts as
independent determinant for change in plasma total peroxide level
(index ∗ HbA1c).
Independent variable Estimate Sig.
Intercept 6.11 (0.58) 0.000
Previous pregnancy 0.40 (0.13) 0.004
Previous insulin treatment 0.32 (0.17) 0.058
logCRP 0.05 (0.02) 0.015
HbA1c −0.03 (0.10) 0.743
Index 0.96 (0.03) 0.002
Index ∗ HbA1c −0.15 (0.05) 0.004
Index ∗ logCRP 0.01 (0.01) 0.194
Index ∗ previous pregnancy −0.08 (0.07) 0.234
Index ∗ previous insulin treatment −0.09 (0.08) 0.274
Dependent variable: log peroxide.N = 61. Values are estimated eﬀect sizes: B
(SE) (Although in the table the parameter estimate of index is positive and
statistically signiﬁcant, it does not mean that peroxide level actually
increased between the two time points, as it refers to the counterfactual
case when all interaction parameters are zero).
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elevation of plasma glucose levels. The elevation in oxidative
stress that can be measured years after pregnancy may reﬂect
the biological cost of reproduction in humans and may also
play a role in the increased metabolic risk observed in women
with multiple pregnancies or with a history of severe gesta-
tional diabetes mellitus.
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